Novo Nordisk A/S
SWB:NOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
SWB:NOVA
|
DK |
|
G
|
Grindrod Ltd
JSE:GND
|
ZA |
|
Pinnacle Financial Partners Inc
NASDAQ:PNFP
|
US |
|
Orell Fuessli AG
SIX:OFN
|
CH |
|
M
|
Microsoft Corp
XHAM:MSF
|
US |
|
Infratil Ltd
NZX:IFT
|
NZ |
|
Valneva SE
NASDAQ:VALN
|
FR |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
O
|
Optimi Health Corp
CNSX:OPTI
|
CA |
|
Bayan Resources Tbk PT
F:BNB
|
ID |
|
P
|
Palfinger AG
F:PFI
|
AT |
|
Powell Industries Inc
NASDAQ:POWL
|
US |
|
Meier Tobler Group AG
SIX:MTG
|
CH |
|
Metropole Television SA
PAR:MMT
|
FR |
|
Certara Inc
NASDAQ:CERT
|
US |
|
P
|
Progressive Corp
LSE:0KOC
|
US |
|
Japan Real Estate Investment Corp
TSE:8952
|
JP |
|
American Airlines Group Inc
NASDAQ:AAL
|
US |
|
Nintendo Co Ltd
TSE:7974
|
JP |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
Orsted A/S
LSE:0RHE
|
DK |
|
Pfizer Inc
NYSE:PFE
|
US |
Bankruptcy Probability
Novo Nordisk A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novo Nordisk A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
37.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novo Nordisk A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novo Nordisk A/S has total debt of 118.9B DKK. This includes both short-term (0 DKK) and long-term (118.9B DKK) debt.
You can find a full breakdown on its Balance Sheet.
